Back to Search Start Over

Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.

Authors :
Vo CD
Shebert HL
Zikovich S
Dryer RA
Huang TP
Moran LJ
Cho J
Wassarman DR
Falahee BE
Young PD
Gu GH
Heinl JF
Hammond JW
Jackvony TN
Frederick TE
Blair JA
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Dec 01; Vol. 27 (23), pp. 5235-5244. Date of Electronic Publication: 2017 Oct 19.
Publication Year :
2017

Abstract

To address the growing need for new antimicrobial agents, we explored whether inhibition of bacterial signaling machinery could inhibit bacterial growth. Because bacteria rely on two-component signaling systems to respond to environmental changes, and because these systems are both highly conserved and mediated by histidine kinases, inhibiting histidine kinases may provide broad spectrum antimicrobial activity. The histidine kinase ATP binding domain is conserved with the ATPase domain of eukaryotic Hsp90 molecular chaperones. To find a chemical scaffold for compounds that target histidine kinases, we leveraged this conservation. We screened ATP competitive Hsp90 inhibitors against CckA, an essential histidine kinase in Caulobacter crescentus that controls cell growth, and showed that the diaryl pyrazole is a promising scaffold for histidine kinase inhibition. We synthesized a panel of derivatives and found that they inhibit the histidine kinases C. crescentus CckA and Salmonella PhoQ but not C. crescentus DivJ; and they inhibit bacterial growth in both Gram-negative and Gram-positive bacterial strains.<br /> (Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
27
Issue :
23
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
29110989
Full Text :
https://doi.org/10.1016/j.bmcl.2017.10.036